Answers are grounded in this paper and cite their sources.
Antimicrobial resistance (AMR) is frequently associated with biological fitness costs that arise from disruptions to essential cellular processes, including alterations in antibiotic targets, changes in cellular metabolism, membrane remodeling, and expression of resistance determinants. These costs are expected to reduce bacterial competitiveness in antibiotic-free environments and promote the decline of resistant populations following antibiotic withdrawal. However, antimicrobial resistance often persists despite reduced selective pressure, challenging the assumption that resistance is intrinsically self-limiting. Increasing evidence demonstrates that bacteria can mitigate fitness burdens through compensatory evolution, involving secondary mutations, regulatory adaptation, metabolic rewiring, and epistatic interactions that restore fitness while preserving resistance phenotypes. The magnitude of fitness cost and the capacity for compensation vary according to the underlying resistance mechanism, genetic background, and environmental context. This review summarizes the molecular basis of fitness costs associated with chromosomal and horizontally acquired resistance mechanisms, including target modification, enzyme-mediated resistance, efflux pump overexpression, and reduced membrane permeability. We further discuss experimental approaches used to measure microbial fitness, mechanisms that stabilize resistance in antibiotic-free environments, and the role of compensatory evolution in the long-term persistence of resistant strains. Finally, we highlight the clinical implications of these processes for antimicrobial stewardship, resistance surveillance, and future evolution-informed therapeutic strategies.
No takes yet. Share an insight, caveat, or question.
Zoghby et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: